Watching Picard Medical, Inc.? See every signal: funding, hires, M&A, contracts, sentiment.
Book a demoChoose your planPicard Medical, Inc.
picardmedical.comAI Executive Summary
AI-powered analysis of 10-Q filing content
Picard Medical's liquidity position has collapsed dramatically, with cash falling from $7.45M to just $38K and restricted cash fully depleted from $4.0M between December 2025 and June 2026. Despite growing revenue, the company continues to post substantial operating losses ($9.1M for six months) and has incurred massive non-operating losses from debt settlements and warrant exchanges, driving accumulated deficit up to $90.1M. Persistent material weaknesses in internal controls and a near-zero cash balance raise significant going concern doubts about the company's ability to fund operations.
Red Flags Detected (11)
Cash and cash equivalents plummeted from $7,451K to $38K (99.5% decline) in six months
Restricted cash fully depleted from $4,000K to $0
Total assets nearly halved from $22,548K to $9,167K
8 more red flags detected
Key Takeaways
Company's cash position is critically low at $38K, an existential liquidity risk given ongoing operating losses of over $4.6M per quarter
Revenue grew year-over-year (total revenue $2,954K vs $2,131K for Q2), showing some commercial traction with the SynCardia TAH
3 more takeaways
Filing Overview
What This Means
High Risk Filing: This company is showing signs of financial stress or significant operational challenges.
Deteriorating Trend: Conditions are worsening compared to previous filings. This may create opportunities for service providers.
Quarterly Report: Interim filing with unaudited financial data for the quarter.